Theriva Biologics, Inc. Amortization
Theriva Biologics, Inc. (TOVX) reported Amortization of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2013-04-16
- Theriva Biologics, Inc. amortization for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Theriva Biologics, Inc. amortization for fiscal 2011 was $57.00K.
- Theriva Biologics, Inc. amortization for fiscal 2010 was $0.00.
| Period end | Amortization 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-04-16 |
| 2011-12-31 | $57.00K 10-K · filed 2013-04-16 |
| 2010-12-31 | $0.00 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |